Arrowhead to Present at Needham Healthcare Conference
Needham Healthcare Conference 2013
PASADENA, Calif. -- April 24, 2013
Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics
company, today announced that its COO and Head of R&D, Dr. Bruce Given, will
present at the Needham Healthcare Conference on Tuesday, April 30 at 8:40 a.m.
Eastern time at the Westin Grand Central Hotel in New York City.
A live webcast of the presentation can be accessed by visiting the News &
Events section of the company’s website,
http://www.arrowheadresearch.com/presentations. A replay will also be archived
on the website and available for 60 days.
About Arrowhead Research Corporation
Arrowhead Research Corporation is a clinical stage targeted therapeutics
company with development programs in oncology, obesity, and chronic hepatitis
B virus infection. The company is leveraging its platform technologies to
design and develop peptide-drug conjugates (PDCs) that specifically home to
cell types of interest while sparing off-target tissues, create targeted drugs
based on the gene silencing RNA interference (RNAi) mechanism, and work with
partners to create improved versions of traditional small molecule drugs.
For more information please visit http://www.arrowheadresearch.com, or follow
us on Twitter @ArrowRes. To be added to the Company's email list to receive
news directly, please send an email to email@example.com.
Arrowhead Research Corporation
Vince Anzalone, CFA
The Trout Group
Press spacebar to pause and continue. Press esc to stop.